APA (7th ed.) Citation

Birkner, B., Rech, J., & Stargardt, T. Cost-utility analysis of de-escalating biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Birkner, Benjamin, Jürgen Rech, and Tom Stargardt. Cost-utility Analysis of De-escalating Biological Disease-modifying Anti-rheumatic Drugs in Patients with Rheumatoid Arthritis. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Birkner, Benjamin, et al. Cost-utility Analysis of De-escalating Biological Disease-modifying Anti-rheumatic Drugs in Patients with Rheumatoid Arthritis. Public Library of Science (PLoS).